Newtyn Management, LLC - MERRIMACK PHARMACEUTICALS IN ownership

MERRIMACK PHARMACEUTICALS IN's ticker is MACK and the CUSIP is 590328209. A total of 77 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q2 2018. The put-call ratio across all filers is 0.19 and the average weighting 0.0%.

Quarter-by-quarter ownership
Newtyn Management, LLC ownership history of MERRIMACK PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$23,102,647
+0.2%
1,873,6940.0%5.70%
+4.7%
Q2 2023$23,046,436
+0.1%
1,873,6940.0%5.44%
+20.3%
Q1 2023$23,027,699
+13.6%
1,873,694
+6.0%
4.52%
+8.2%
Q4 2022$20,265,795
+205.8%
1,768,394
+0.1%
4.18%
+187.4%
Q3 2022$6,627,000
-36.6%
1,767,094
+0.5%
1.46%
-26.6%
Q2 2022$10,460,000
-3.4%
1,758,005
+2.6%
1.98%
-23.6%
Q1 2022$10,830,000
+78.8%
1,713,612
+10.6%
2.59%
+61.3%
Q4 2021$6,056,000
-19.0%
1,548,8830.0%1.61%
-19.4%
Q3 2021$7,481,000
-24.2%
1,548,8830.0%2.00%
-27.0%
Q2 2021$9,866,000
+1.8%
1,548,8830.0%2.73%
+4.4%
Q1 2021$9,696,000
-9.1%
1,548,8830.0%2.62%
+6.5%
Q4 2020$10,672,000
+105.8%
1,548,883
+19.5%
2.46%
+95.5%
Q3 2020$5,186,000
+29.8%
1,296,436
+8.1%
1.26%
-14.0%
Q2 2020$3,995,000
+58.4%
1,199,606
+2.3%
1.46%
+68.4%
Q1 2020$2,522,000
-31.7%
1,173,1660.0%0.87%
+154.5%
Q4 2019$3,695,000
-29.9%
1,173,1660.0%0.34%
-31.2%
Q3 2019$5,268,000
-28.2%
1,173,166
-3.2%
0.50%
-47.6%
Q2 2019$7,333,000
-7.8%
1,212,144
+5.9%
0.95%
-37.0%
Q1 2019$7,955,000
+131.9%
1,144,583
+28.8%
1.50%
+124.1%
Q4 2018$3,430,000
-4.7%
888,620
+31.6%
0.67%
+8.9%
Q3 2018$3,598,000
+15.7%
675,000
+6.6%
0.62%
+5.8%
Q2 2018$3,109,000
+174.2%
633,297
+349.6%
0.58%
+188.1%
Q1 2018$1,134,000
-69.5%
140,857
-61.1%
0.20%
-64.4%
Q4 2017$3,714,000
-34.5%
362,335
-7.1%
0.57%
-38.0%
Q3 2017$5,671,000390,0000.92%
Other shareholders
MERRIMACK PHARMACEUTICALS IN shareholders Q2 2018
NameSharesValueWeighting ↓
22NW, LP 749,302$2,892,0001.80%
Clearline Capital LP 316,425$1,221,0000.84%
Newtyn Management, LLC 888,620$3,430,0000.67%
Western Standard LLC 150,363$580,0000.54%
WITTENBERG INVESTMENT MANAGEMENT, INC. 222,467$859,0000.40%
BVF INC/IL 721,935$2,787,0000.36%
Sepio Capital, LP 411,676$1,589,0000.12%
Yakira Capital Management, Inc. 66,934$258,0000.09%
J. Goldman & Co LP 152,095$587,0000.04%
Spark Investment Management LLC 48,909$188,0000.01%
View complete list of MERRIMACK PHARMACEUTICALS IN shareholders